Skip to main content
. 2017 Nov 13;11(4):242–251. doi: 10.1007/s12281-017-0304-7

Table 2.

Initial assessment of patients with CPA

Inflammatory markers
CRP Raised in CPA, used to monitor progress and response to therapy [25]
ESR/plasma viscosity
Immunology
Aspergillus IgG Raised in CPA, used to monitor progress and response to therapy
Aspergillus IgE Raised in ABPA
Microbiology
Sputum C and S To rule out resistance, co-infections
Sputum Aspergillus PCR Baseline, probably more sensitive than culture
Imaging
CXR Baseline imaging, ideally CT Chest. Repeat after 6 months of treatment, 1–2 yearly thereafter with low dose scanning [2, 18]
CT chest
Miscellaneous
St George Quality of Life questionnaire At baseline, used to monitor response to therapy [2628]
Weight
MRC dyspnoea scale
Pulmonary function tests
Assessment for immunodeficiency Poor antibody responses to S. pneumoniae, H. influenzae are common [29], as are reduced NK, B and CD4 cell counts [30]